Neuroscience in Discovery & Development Congress

Oxford Global is proud to present the Neuroscience in Discovery & Development Congress, taking place on 11 - 12 June 2019 in Berlin, Germany featuring over 20 presentations on the latest strategies & technologies impacting the neuroscience field.

 

Our conference delivers an extensive look across the development process in the neuroscience field; from identifying & validating molecular targets to patient stratification & diagnostics. Further talks include an overview of biomarkers in neuroscience & the use of CRISPR screening.

Day one of the congress will focus on the latest drug discovery strategies in CNS, including the use of iPS Cells in Neuropharmacology & the role of stem cell research in identifying neurodegenerative disorders. Delegates can further expect to benefit from the latest in neuroimaging. Day 2 will focus on biomarkers in patient stratification & identification of neurological disorders.

 

Key speakers include vice presidents, executive directors & heads from leading pharmaceutical & biotech companies such as Takeda, Boehringer Ingelheim & Novartis. The event is co-located with our well established 20th Annual Drug Discovery Summit, 7th Annual Discovery Chemistry & Drug Design Congress & the Bispecifics Drug Development Congress. This 2-day interactive congress will allow delegates to discuss the latest industry & developments with over 500 senior level delegates.

 

2 Interactive Streams:

• Drug Discovery Strategies in CNS
• Translation, Stratification and Precision Medicine In Neuroscience
  

View the agenda: https://bit.ly/2RWq9TC

 

For further information about the congress, please contact Guillaume Alonso at g.alonso@oxfordglobal.co.uk or visit the website https://bit.ly/2RW0RWp